These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 8971168)

  • 1. Preclinical development of a recombinant toxin containing circularly permuted interleukin 4 and truncated Pseudomonas exotoxin for therapy of malignant astrocytoma.
    Puri RK; Hoon DS; Leland P; Snoy P; Rand RW; Pastan I; Kreitman RJ
    Cancer Res; 1996 Dec; 56(24):5631-7. PubMed ID: 8971168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased antitumor activity of a circularly permuted interleukin 4-toxin in mice with interleukin 4 receptor-bearing human carcinoma.
    Kreitman RJ; Puri RK; Pastan I
    Cancer Res; 1995 Aug; 55(15):3357-63. PubMed ID: 7614471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a recombinant interleukin-4-Pseudomonas exotoxin for therapy of glioblastoma.
    Puri RK
    Toxicol Pathol; 1999; 27(1):53-7. PubMed ID: 10367674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An improved circularly permuted interleukin 4-toxin is highly cytotoxic to human renal cell carcinoma cells. Introduction of gamma c chain in RCC cells does not improve sensitivity.
    Puri RK; Leland P; Obiri NI; Husain SR; Mule J; Pastan I; Kreitman RJ
    Cell Immunol; 1996 Jul; 171(1):80-6. PubMed ID: 8660841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human breast carcinoma cells express type II IL-4 receptors and are sensitive to antitumor activity of a chimeric IL-4-Pseudomonas exotoxin fusion protein in vitro and in vivo.
    Leland P; Taguchi J; Husain SR; Kreitman RJ; Pastan I; Puri RK
    Mol Med; 2000 Mar; 6(3):165-78. PubMed ID: 10965493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-4 receptor cytotoxin as therapy for human malignant pleural mesothelioma xenografts.
    Beseth BD; Cameron RB; Leland P; You L; Varricchio F; Kreitman RJ; Maki RA; Jablons DM; Husain SR; Puri RK
    Ann Thorac Surg; 2004 Aug; 78(2):436-43; discussion 436-43. PubMed ID: 15276492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumoral administration of recombinant circularly permuted interleukin-4-Pseudomonas exotoxin in patients with high-grade glioma.
    Rand RW; Kreitman RJ; Patronas N; Varricchio F; Pastan I; Puri RK
    Clin Cancer Res; 2000 Jun; 6(6):2157-65. PubMed ID: 10873064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human neurological cancer cells express interleukin-4 (IL-4) receptors which are targets for the toxic effects of IL4-Pseudomonas exotoxin chimeric protein.
    Puri RK; Leland P; Kreitman RJ; Pastan I
    Int J Cancer; 1994 Aug; 58(4):574-81. PubMed ID: 8056454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete regression of established human glioblastoma tumor xenograft by interleukin-4 toxin therapy.
    Husain SR; Behari N; Kreitman RJ; Pastan I; Puri RK
    Cancer Res; 1998 Aug; 58(16):3649-53. PubMed ID: 9721874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human renal cell carcinoma cells are sensitive to the cytotoxic effect of a chimeric protein composed of human interleukin-4 and Pseudomonas exotoxin.
    Puri RK; Debinski W; Obiri N; Kreitman R; Pastan I
    Cell Immunol; 1994 Apr; 154(1):369-79. PubMed ID: 8131209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-4 receptors on human medulloblastoma tumours serve as a sensitive target for a circular permuted IL-4-Pseudomonas exotoxin fusion protein.
    Joshi BH; Leland P; Silber J; Kreitman RJ; Pastan I; Berger M; Puri RK
    Br J Cancer; 2002 Jan; 86(2):285-91. PubMed ID: 11870521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-4-Pseudomonas exotoxin chimeric fusion protein for malignant glioma therapy.
    Kawakami M; Kawakami K; Puri RK
    J Neurooncol; 2003 Oct; 65(1):15-25. PubMed ID: 14649882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo studies of antitumor effects of the recombinant immunotoxin MSH-PE38KDEL on melanoma.
    Hui Q; Ma J; Song J; Liu Z; Ren H; Jiang W; Wang Y; Xu Y; Guo D; Zhang X; Lu S
    Neoplasma; 2014; 61(4):392-400. PubMed ID: 25027740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cintredekin besudotox in treatment of malignant glioma.
    Mut M; Sherman JH; Shaffrey ME; Schiff D
    Expert Opin Biol Ther; 2008 Jun; 8(6):805-12. PubMed ID: 18476792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant heregulin-Pseudomonas exotoxin fusion proteins: interactions with the heregulin receptors and antitumor activity in vivo.
    Yang D; Kuan CT; Payne J; Kihara A; Murray A; Wang LM; Alimandi M; Pierce JH; Pastan I; Lippman ME
    Clin Cancer Res; 1998 Apr; 4(4):993-1004. PubMed ID: 9563895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-4 receptor expression on AIDS-associated Kaposi's sarcoma cells and their targeting by a chimeric protein comprised of circularly permuted interleukin-4 and Pseudomonas exotoxin.
    Husain SR; Gill P; Kreitman RJ; Pastan I; Puri RK
    Mol Med; 1997 May; 3(5):327-38. PubMed ID: 9205948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomonas exotoxin-based immunotoxins containing the antibody LL2 or LL2-Fab' induce regression of subcutaneous human B-cell lymphoma in mice.
    Kreitman RJ; Hansen HJ; Jones AL; FitzGerald DJ; Goldenberg DM; Pastan I
    Cancer Res; 1993 Feb; 53(4):819-25. PubMed ID: 8428363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ expression of interleukin-4 (IL-4) receptors in human brain tumors and cytotoxicity of a recombinant IL-4 cytotoxin in primary glioblastoma cell cultures.
    Joshi BH; Leland P; Asher A; Prayson RA; Varricchio F; Puri RK
    Cancer Res; 2001 Nov; 61(22):8058-61. PubMed ID: 11719427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A chimeric protein comprised of IL-4 and Pseudomonas exotoxin is cytotoxic for activated human lymphocytes.
    Puri RK; Mehrotra PT; Leland P; Kreitman RJ; Siegel JP; Pastan I
    J Immunol; 1994 Apr; 152(7):3693-700. PubMed ID: 8144944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A wide range of human cancers express interleukin 4 (IL4) receptors that can be targeted with chimeric toxin composed of IL4 and Pseudomonas exotoxin.
    Debinski W; Puri RK; Kreitman RJ; Pastan I
    J Biol Chem; 1993 Jul; 268(19):14065-70. PubMed ID: 8314773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.